Clinical Trial Update: Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and pharmacokinetics of an investigational injectable HIV medicine (GSK1265744) in HIV-uninfected adults has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• GSK1265744 (dolutegravir? wait: GSK1265744 is cabotegravir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-07-05